Source: Annual Congress 2003 - Pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Chaouat, F. Coulet, G. Simonneau, E. Weitzenblum, F. Soubrier, M. Humbert (Strasbourg, Paris, Clamart, France). Endoglin germline mutation, hereditary hemorrhagic telangiectasia and fenfluramine-associated pulmonary arterial hypertension. Eur Respir J 2003; 22: Suppl. 45, 2935

Member's Comments

No comment yet.

Related content which might interest you: The pulmonary vascular complications of hereditary haemorrhagic telangiectasia Source: Eur Respir J 2009; 33: 1186-1194 Year: 2009 Primary pulmonary hypertension in families with hereditary haemorrhagic telangiectasia Source: Eur Respir J 2004; 23: 373-377 Year: 2004 Clinical characteristics, hemodynamics and survival in idiopathic and familial pulmonary arterial hypertension with germline BMPR2 mutation Source: Eur Respir J 2007; 30: Suppl. 51, 250s Year: 2007 Pulmonary hypertension in hereditary hemorrhagic telangiectasia is associated with multiple clinical conditions Source: International Congress 2019 – Pulmonary hypertension: clinical Year: 2019 Pulmonary hypertension in hereditary haemorrhagic telangiectasia is associated with multiple clinical conditions Source: ERJ Open Res, 7 (1) 00078-2020; 10.1183/23120541.00078-2020 Year: 2021 Familial pulmonary arterial hypertension by KDR heterozygous loss of function Source: Eur Respir J, 55 (4) 1902165; 10.1183/13993003.02165-2019 Year: 2020 Fatal rupture of pulmonary arteriovenous malformation in hereditary haemorrhagic telangiectasis and severe PAH Source: Eur Respir Rev 2009; 18: 42-46 Year: 2009 Genetic epidemiology of hereditary hemorrhagic telangiectasia associated with pulmonary arteriovenous malformation Source: Annual Congress 2012 - Epidemiology of various respiratory diseases Year: 2012 Clinical manifestation of hereditary pulmonary arterial hypertension by a ²second hit² mutation in the genes BMPR2 and EIF2AK4 Source: International Congress 2016 – Pulmonary hypertension: the clinic I Year: 2016 Pre-implantation genetic diagnosis in pulmonary arterial hypertension due to BMPR2 mutation Source: Eur Respir J 2012; 39: 1534-1535 Year: 2012 Prevalence of pulmonary hypertension in a large cohort of patients with hereditary hemorrhagic telangiectasia Source: International Congress 2015 – Pulmonary hypertension: novel clinical insights Year: 2015 BMPR2 mutations in pulmonary arterial hypertension with congenital heart disease Source: Eur Respir J 2004; 24: 371-374 Year: 2004 Genetic epidemiology of hereditary hemorrhagic telangiectasia complicated with pulmonary arteriovenous malformation Source: Annual Congress 2011 - Genetics of airway diseases and treatment Year: 2011 TBX4 syndrome: a systemic disease highlighted by pulmonary arterial hypertension in its most severe form Source: Eur Respir J, 55 (5) 2000585; 10.1183/13993003.00585-2020 Year: 2020 Screening of pulmonary arterial hypertension in BMPR2 mutation carriers Source: Virtual Congress 2020 – Genetics and genomics of pulmonary arterial hypertension Year: 2020 Pulmonary arterial hypertension preceding idiopathic pulmonary fibrosis in a BMPR2 mutation positive patient Source: Eur Respir Rev 2014; 23: 147-149 Year: 2014 Pulmonary arteriovenous malformations and hereditary hemorrhagic telangiectasia. A case report and family screening Source: Eur Respir J 2003; 22: Suppl. 45, 583s Year: 2003 How to follow-up patients with hereditary haemorrhagic telangiectasia and suspected pulmonary arteriovenous malformations Source: Eur Respir J 2016; 47:1618-1621 Year: 2016